Valion Bio Inc (VBIO) — Capital Reinvestment Ratio
Latest as of September 2025:
0.01x
Valion Bio Inc (VBIO) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($964.82K) in capital expenditures ($10.00K). See Valion Bio Inc (VBIO) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$964.82K
USD
Capital Expenditures
$10.00K
USD
Data as of
Sep 2025
Most recent filing
Annual Capital Reinvestment Ratio for Valion Bio Inc (None–None)
Year-by-year Capital Reinvestment Ratio for Valion Bio Inc from None to None. For live market cap and broader valuation context, see VBIO market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow